Abstract
Objectives:
Night shift work has been suggested as a possible risk factor for multiple sclerosis (MS). The objective of the present analysis was to prospectively evaluate the association of rotating night shift work history and MS risk in two female cohorts, the Nurseś Health Study (NHS) and NHSII.
Methods:
A total of 83,992 (NHS) and 114,427 (NHSII) women were included in this analysis. We documented 579 (109 in NHS, 470 in NHSII) incident physician confirmed MS cases (moderate and definite diagnosis), including 407 definite MS cases. The history (cumulative years) of rotating night shifts (≥3 nights/month) was assessed at baseline and updated throughout follow-up. Cox proportional hazards models were used to estimate hazard ratios (HR) and 95% confidence intervals (CIs) for the association between rotating night shift work and MS risk adjusting for potential confounders.
Results:
We observed no association between history of rotating night shift work and MS risk in NHS (1–9years: HR 1.03, 95%CI 0.69–1.54; 10+years: 1.15, 0.62–2.15) and NHSII (1–9years: HR 0.90, 95%CI 0.74–1.09; 10+years: 1.03, 0.72–1.49). In NHSII, rotating night shift work history of 20+ years was significantly associated with MS risk, when restricting to definite MS cases (1–9years: HR 0.88, 95%CI 0.70–1.11; 10–19years: 0.98, 0.62–1.55; 20+years: 2.62, 1.06–6.46).
Conclusions:
Overall, we found no association between rotating night shift work history and MS risk in these two large cohorts of nurses. In NHSII, shift work history of 20 or more years was associated with an increased risk of definite MS diagnosis.
Keywords: night shift work, shift work, circadian disruption, multiple sclerosis, cohort study
INTRODUCTION
Increasing evidence suggests that night shift work and exposure to light at night are associated with a higher risk of chronic disease outcomes including cancer and cardiovascular disease1–4. Recent studies show that night shift workers may also be at an increased risk of autoimmune diseases such as multiple sclerosis (MS), psoriasis and hypothyroidism5–9. Two previous studies found that shift work was associated with a higher risk of MS, particularly among participants exposed early in life (before age 20 years)6 10. A third study found no overall association between shift work and risk of MS5. The epidemiological evidence is still very limited and no prospective study has evaluated the possible link between night shift work and MS risk.
The association between night shift work and MS risk is biologically plausible. Night shift work causes circadian disruption, sleep deprivation and melatonin suppression that may in turn impact the immune function11. In mouse models of MS, circadian rhythms such as liver clock gene expression, corticosterone and leptin rhythms, have been shown to be altered, which is supportive of a link between circadian disruption and autoimmune inflammatory disease12. In experimental and observational human studies circadian disruption and sleep deprivation, two common consequences of night shift work, have been linked with increased inflammatory biomarkers and lower melatonin levels13–16. Melatonin is a well-known immunomodulator and may be a potential key hormone in MS onset17. Melatonin levels have been shown to correlate negatively with multiple sclerosis activity in humans18. In clinical studies circulating melatonin levels were found to be predictive of MS severity19 and exogenous melatonin was shown to reduce inflammatory response in MS patients20. These findings suggest that night work that involves circadian disruption may have implications for MS etiology and progression.
In the present study we prospectively examined the association between the history (cumulative years) of rotating night shift work and occurrence of MS in two prospective cohorts of US women, the Nurses’ Health Study (NHS) and NHSII.
METHODS
Study participants
The NHS recruited 121,701 female nurses aged 30–55 years old in 1976 and the NHSII 116,430 female nurses aged 25–42 years old in 1989. Every two years, women completed a questionnaire to update lifestyle exposures and medical conditions. The first assessment of night work history was in 1988 in NHS and in 1989 in NHSII; the return dates of these questionnaires were the start of follow-up (baseline) for each cohort, respectively. After excluding participants with missing shift work information at baseline, MS diagnosis before baseline or missing date of MS diagnosis, there were 83,992 women in NHS and 114,427 women in NHSII included in the analysis.
Standard protocol approvals, registrations, and patient consents
This study was approved by the institutional review board of Brigham and Women’s Hospital Investigators received written informed patient consent to perform this study.
Ascertainment of MS cases
Participants with newly diagnosed MS self-reported on biennial questionnaires were asked for permission by investigators to contact their neurologists and review their medical records, clinical history (including diagnosis date and date of first symptoms), and the neurologist’s certainty of diagnosis (definite, probable, possible, not MS). Since 2003, the study neurologist (T.C.) has reviewed all medical records. If a neurologist did not respond, a questionnaire was sent to the participant’s internist. For 90% of women with MS, the treating physician was a neurologist. In most cases, diagnosis was supported by magnetic resonance imaging (MRI) findings (>70% NHS; >90% NHSII)21. For these analyses, we defined confirmed cases as those with definite or probable MS according to neurologist or internist. Using this definition, we confirmed a total of 579 new MS cases in both cohorts; 109 of them occurred in the NHS cohort and 470 cases in NHSII. Secondary analyses were restricted to the 407 definite cases of MS (NHS: 73 cases, NHSII: 334 cases).
Night-shift work assessment
Information on total years during which the nurse had worked rotating night shifts was available at baseline (1988/1989 questionnaires) in both cohorts. Specifically, the question was: “What is the total number of years during which you worked rotating night shifts (at least 3 nights/month in addition to days or evenings in that month)?” The pre-specified response categories were: “Never; 1–2 years; 3–5 yrs; 6–9 yrs; 10–14 yrs; 15–19 yrs; 20 years or more”. In the NHSII this information was updated over follow-up by asking women how many months of rotating night shifts they worked during the two-year periods subsequent to each biennial questionnaire in 1991, 1993, 1997, 2001, 2005, and 2007; pre-specified response categories were: none, 1–4 months, 5–9, 10–14, 15–19, and ≥20 months. Because the NHSII questionnaires of 1995 and 2003 did not contain a question updating this information, retrospective assessment of rotating night shifts for the periods 1997–1999 and 2001–2003 were included on the 2001 and 2005 questionnaires, respectively. We calculated the total number of years having worked rotating night shifts for at least 3 times per month over a nurse’s career. If shift work information was missing in one of the follow-up cycles, we assigned 0 months to that cycle and kept women in the analysis.
Covariates
Information on demographics, lifestyle and diet was reported on biennial questionnaires and updated through follow-up. Women reported information on state of residence at ages 15 (1992 in NHS; 1993 in NHSII) and ancestry (1992 in NHS; 1989 in NHSII; South European, Scandinavian, other Caucasian, African American, Hispanic, Asian, Native American (NHS only), other) and were categorized as previously described 21. Women updated smoking status every two years; pack-years of smoking were derived from this information. Women completed comprehensive validated semi-quantitative food frequency questionnaires every four years and supplemental vitamin D intake (IU/day) was derived using reported intake22. Women reported their current height (1976 in NHS; 1989 in NHSII) and weight at age 18 (1980 in NHS; 1989 in NHSII); body mass index (BMI) at age 18 was calculated by dividing age 18 weight (in kilograms) by reported height (in meters) squared.
Statistical analysis
Baseline characteristics (NHS: 1988; NHSII: 1989) of the study population were age-standardized and reported by rotating night shift work history and cohort. Participants contributed person-time to the follow up period from the date of first shift work assessment (1988 in NHS and 1989 in NHSII) to the date of diagnosis of MS, death from any cause, or end of follow-up (May 31, 2004 for NHS and May 31, 2011 for NHSII). Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) related to MS risk (moderate and definite diagnosis), for each shift work history category. The reference group comprised of nurses who never worked rotating night shifts. Pre-determined cut points of shift work history (total years) were used to classify participants (0, 1–9 years, 10+ years of rotating night shift work) in both cohorts. An additional exposure classification was used only in NHSII, where power was sufficient, to capture even longer durations of cumulative updated shift work history (0, 1–9, 10–19, 20+ years of rotating night shift work). To account for potential confounding by age and time all models were adjusted for age (5-year age groups) and 2-year time intervals. The fully (multivariable) adjusted models were additionally adjusted for known and suspected MS risk factors23 24 such as ancestry (southern European, Scandinavian, other Caucasian, and non-white), latitude of state of residence at age 15 (northern, middle, southern states), BMI at age 18 (<18.5, 18.5–20.9, 21–22.9, 23–24.9, 25–26.9, 27–29.9, ≥30 kg/m2), intake of vitamin D from supplements (none, <400, ≥400 IUs/day), pack years of smoking (0, <10, 10–24, 25+ pks/yr). Missing indicators were used for covariates with missing information. Tests for trend were conducted by modeling the median values of each category of night shift work history as a continuous variable. In secondary analysis we used a more stringent definition for MS by restricting the analysis to only definite diagnosis of MS and recomputed HRs and 95%CI according to cumulative years of rotating night shift work. Stratified analyses were performed to examine effect modification by BMI at age 18 and smoking. In sensitivity analyses, the date of first symptoms of MS (instead of date of MS diagnosis) was used for person-time calculation and time to event analysis. In these analyses, subjects with reported symptoms before baseline were additionally excluded in order to restrict to truly incident MS cases and minimize the potential for reverse causality. Risk estimates (HRs and 95% CI) were recalculated for all exposure categories and both MS definitions (moderate/definite and definite diagnoses). All p values were 2-sided. All analyses were conducted using Statistical Analysis System (SAS), version 9.3.
RESULTS
As expected, compared to women in NHSII, women in NHS were older at baseline (54.9 yrs; SD 7.2 vs 34.3 yrs; SD 4.7) and at age of MS diagnosis (59.2 years; SD 6.9 vs 44.5 years; SD 6.8). In both cohorts, women with longer history of shift work at baseline were older, had greater BMIs and were more likely to be non-white and heavy smokers, compared to never shift workers (Table 1). Overall, we observed no significant association between number of years of rotating night shifts at baseline and MS risk among women in the NHS cohort (1–9 yrs: multivariable adjusted HR 1.03, 95%CI 0.69, 1.54; 10+ yrs: HR 1.15 95%CI 0.62, 2.15; PTrend=0.61), (Table 2). Similarly, in NHSII, neither baseline nor updated history of rotating night shift work was associated with MS risk. In NHSII, nurses who had worked rotating night shifts for more than 20 years had an 80% increased MS risk in the fully adjusted models, compared to never shift workers, but differences were not statistically significant. In secondary analyses restricted to definite MS cases, associations between longer durations of rotating night shift work and MS risk became stronger in both cohorts (Table 3). Using this more stringent definition of MS, 20+ years of rotating night shift work was associated with a 2.6-fold increase in MS risk which remained significant in the fully adjusted models (HR=2.61, 95%CI 1.06–6.47; PTrend =0.50), although this was based on 5 MS cases. Further, in stratified analyses we found no evidence of effect modification by BMI at age 18 and smoking, but estimates were unstable due to small case numbers (results not shown).
Table 1.
Age-standardized* baseline characteristics of the study population by rotating night shift work history (NHS I: 1988, NHS II: 1989)
NHS I (N= 83,992) | NHS II (N=114,427) | |||||
---|---|---|---|---|---|---|
Shift work history | Shift work history | |||||
Never (N=33,882) | 1–9 years (N=39,968) | 10+ years (N=10,142) | Never (N=43,487) | 1–9 years (N=65,697) | 10+ years (N=5,243) | |
Age (years); mean (SD) | 54.5(7.1) | 54.8(7.1) | 56.6(6.9) | 34.3(4.7) | 34.2(4.7) | 36.9(3.4) |
BMI age 18 (kg/m2); mean (SD) | 21.3(2.9) | 21.4(2.9) | 21.8(3.3) | 21.1(3.2) | 21.3(3.4) | 22.0(4.2) |
Pack-years of smoking,(%) | ||||||
0 pack-yrs | 46.2 | 44.0 | 42.7 | 67.3 | 64.5 | 60.1 |
1–9 pack-yrs | 16.9 | 17.9 | 14.6 | 16.1 | 17.5 | 18.6 |
10–24 pack-yrs | 15.5 | 15.7 | 15.8 | 14.3 | 15.4 | 18.0 |
25+ pack-yrs | 21.5 | 22.4 | 27.0 | 2.4 | 2.6 | 3.3 |
Vitamin D (IUs /day) supplement use (%) | ||||||
None, | 59.7 | 59.0 | 60.0 | 58.9 | 57.9 | 53.4 |
<400 IU/d, | 17.7 | 18.6 | 18.9 | 19.2 | 20.0 | 21.9 |
>= 400 IU/d, | 22.6 | 22.4 | 21.1 | 22.0 | 22.2 | 24.7 |
Latitude at age 15 (%) | ||||||
Northern states | 42.9 | 41.8 | 38.6 | 34.8 | 34.1 | 31.8 |
Middle states | 48.2 | 50.5 | 53.8 | 48.2 | 51.5 | 57.3 |
Southern states | 8.9 | 7.7 | 7.6 | 17.0 | 14.4 | 10.9 |
Ethnicity (%) | ||||||
Southern European | 14.4 | 14.5 | 15.2 | 13.4 | 13.8 | 14.7 |
Scandinavian | 4.2 | 4.2 | 3.5 | 4.3 | 4.5 | 3.8 |
other Caucasian | 60.5 | 61.5 | 54.5 | 73.3 | 71.6 | 69.8 |
non-white | 20.9 | 19.8 | 26.8 | 9.1 | 10.2 | 11.7 |
Values are standardized to the age distribution of the study population.
Table 2.
Relative risk of multiple sclerosis (probable or definite diagnoses)according to cumulative years of rotating night shift work among women in the Nurses’ Health Study (NHS) (N=109 cases) and NHS II (N=470 cases).
Rotating night shift work history (cumulative years) | Cases/person-years | Age-adjusted HR (95% CI)1 | Multivariable-adjusted HR (95% CI) 2 | P trend3 |
---|---|---|---|---|
NHS I (baseline 10+) | ||||
Never | 44/507,650 | 1.00 | 1.00 | |
1–9 years | 52/598,084 | 1.04 (0.70, 1.56) | 1.03 (0.69, 1.54) | |
10+ years | 13/148,033 | 1.23 (0.66, 2.28) | 1.15 (0.62, 2.15) | 0.61 |
NHS II (baseline 10+) | ||||
Never | 189/870,039 | 1.00 | 1.00 | |
1–9 years | 254/1,306,269 | 0.90 (0.74, 1.08) | 0.89 (0.74, 1.07) | |
10+ years | 27/103,293 | 1.18 (0.79, 1.78) | 1.11 (0.74, 1.67) | 0.57 |
NHS II (updated 10+) | ||||
Never | 153/705,558 | 1.00 | 1.00 | |
1–9 years | 281/1,421,902 | 0.92 (0.76, 1.12) | 0.90 (0.74, 1.09) | |
10+ years | 36/152,141 | 1.11 (0.77, 1.60) | 1.03 (0.72, 1.49) | 0.95 |
NHS II (updated 20+) | ||||
Never | 153/705,558 | 1.00 | 1.00 | |
1–9 years | 281/1,421,902 | 0.92 (0.76, 1.12) | 0.90 (0.74, 1.09) | |
10–19 years | 31/140,081 | 1.04 (0.70, 1.53) | 0.97 (0.66, 1.43) | |
20+ years | 5/12,060 | 2.03 (0.83, 4.95) | 1.80 (0.73, 4.40) | 0.80 |
Hazard Ratio (HR) and 95% confidence interval (CI) adjusted for age (5 year categories)
Hazard Ratio (HR) and 95% confidence interval (CI) additionally adjusted for intake of vitamin D supplements (none, <400, ≥400 IUs/day), latitude at age 15 (northern, middle, southern states), pack years of smoking (0, <10, 10–24, ≥25), body mass index at age 18 (<18.5, 18.5–20.9, 21–22.9, 23–24.9, 25–26.9, 27–29.9, ≥30) and ancestry (southern European, Scandinavian, other Caucasian, and non-white)
Calculated using medians of shift work duration categories fully adjusted for all variables listed in model 2.
Table 3.
Relative risk of multiple sclerosis (definite diagnoses) according to cumulative years of rotating night shift work among women in the Nurses’ Health Study (NHS) (N=73 cases) and NHS II (N=334 cases).
Rotating night shift work history (cumulative years) | Cases/person-years | Age-adjusted HR (95% CI)11 | Multivariable-adjusted HR (95% CI)12 | P trend3 |
---|---|---|---|---|
NHS I (baseline 10+) | ||||
Never | 28/507,650 | 1.00 | 1.00 | |
1–9 years | 36/598,084 | 1.13 (0.69, 1.86) | 1.11 (0.68, 1.82) | |
10+ years | 9/148,033 | 1.35 (0.64, 2.88) | 1.27 (0.60, 2.72) | 0.47 |
NHS II (baseline 10+) | ||||
Never | 135/870,090 | 1.00 | 1.00 | |
1–9 years | 176/1,306,345 | 0.87 (0.69, 1.09) | 0.86 (0.69, 1.08) | |
10+ years | 23/103,296 | 1.41 (0.90, 2.20) | 1.32 (0.84, 2.07) | 0.20 |
NHS II (updated 10+) | ||||
Never | 110/705,599 | 1.00 | 1.00 | |
1–9 years | 197/1,421,986 | 0.91 (0.72, 1.15) | 0.88 (0.70, 1.11) | |
10+ years | 27/152,146 | 1.19 (0.78, 1.81) | 1.10 (0.72, 1.69) | 0.96 |
NHS II (updated 20+) | ||||
Never | 110/705,599 | 1.00 | 1.00 | |
1–9 years | 197/1,421,986 | 0.91 (0.72, 1.15) | 0.88 (0.70, 1.11) | |
10–19 years | 22/140,086 | 1.05 (0.66, 1.66) | 0.98 (0.62, 1.55) | |
20+ years | 5/12,060 | 2.98 (1.21, 7.33) | 2.62 (1.06, 6.47) | 0.50 |
Hazard Ratio (HR) and 95% confidence interval (CI) adjusted for age (5 year categories)
Hazard Ratio (HR) and 95% confidence interval (CI) additionally adjusted for intake of vitamin D supplements (none, <400, ≥400 IUs/day), latitude at age 15 (northern, middle, southern states), pack years of smoking (0, <10, 10–24, ≥25), body mass index at age 18 (<18.5, 18.5–20.9, 21–22.9, 23–24.9, 25–26.9, 27–29.9, ≥30); and ancestry (southern European, Scandinavian, other Caucasian, and non-white)
Calculated using medians of shift work duration categories fully adjusted for all variables listed in model 2.
In sensitivity analyses based on the date of first MS symptoms and additional exclusion of women that reported symptoms before baseline, the direction of the association between night shift work history and MS risk was similar to the main analysis in NHSII and slightly stronger in the NHS cohort, though none of the differences were statistically significant, since these analyses were based on a smaller number of cases (Supplemental Tables 1 and 2).
DISCUSSION
In these two large cohorts of nurses we found no evidence of an association between rotating night shift work and MS risk. In NHS and to a less extent in NHSII, we were only able to evaluate later life onset of MS, due to the older age of the nurses at baseline. In NHSII, MS risk tended to increase with longer history of shift work (20+ years) suggesting that long-term or early career circadian disruption might be critical for MS, but our estimates were based on small case numbers and therefore have to be viewed with caution.
Our study consisted of two large cohorts and for the first time prospectively assessed rotating night shift work in relation to MS risk (diagnosis and first symptoms) and could not confirm an overall positive association as was described in some of the previous studies. In a large population based case-control study in Sweden, including incident (N=1,343) and prevalent (N=5,129) MS cases10, shift work before age 20 years - but not after 20 years - increased the risk of MS compared to day shift work. 10 In a subsequent analysis (N=2,337 incident cases) the investigators confirmed the increased MS risk with ever shift work, independently of the age of first exposure, although results were again stronger for early life exposure (<20 yrs) to shift work6. A third case-control study (N=1,723 cases) did not observe a significant association between MS and shift work (ever/never) or shift work duration (years)5. This study described a small increase in risk with shift work intensity (nights/month), but used blood donors as controls which is generally a healthier group compared to the general population25 26.
There are a few reasons why our findings may be different from previous studies. First, all previous studies, although large in size, were potentially affected by selection and information bias - especially recall of past exposures – which may partly explain their positive results. Second, in our analysis because women were relatively older at baseline (especially in NHS and to a lesser extent in NHSII) and only incident MS cases were included, our findings may only apply to later onset MS, as opposed to previous studies that had no restriction regarding age of MS diagnosis. Last, previous studies included shift workers of both sexes from a variety of occupational sectors (shift work systems including both rotating and permanent night work), whereas ours is a study of female nurses, which is a more homogeneous group in terms of exposure (rotating night shift work with ≥3 nights/month) and confounders.
Although we found no overall association between rotating shift work history and MS, our study suggested a possible increased risk of MS with extreme durations (20+ years) of shift work which was statistically significant when the analysis was restricted to definite diagnosis of MS. This finding suggests that long-term circadian disruption may play a role in MS development and given the lack of a significant linear trend this may represent a threshold effect. Alternatively, women with the longest shift work histories (20+ years) might have started shift work at a younger age, which supports the hypothesis that early life circadian disruption may be most critical for MS development, as suggested in previous studies5 10. It is likely that nurses’ exposure to night shift work began early on in their careers during training and first years of practice. However in our cohorts, exact information on shift work timing such as age of first night shift work was not available. Thus, we could not disentangle the effects of early timing of night shift work to those of long shift work duration.
Long-term night shift work leads to chronic circadian disruption and sleep deprivation that in turn may lead to an altered immune response, according to experimental animal and human studies11 12 27. Suggested underlying pathophysiologic mechanisms include oxidative stress and neuroendocrine changes such as increase in glycocorticoids, pro-inflammatory cytokines and leukocyte count that lead to a chronic inflammatory condition28. In addition, melatonin - a hormone that is typically suppressed by light in night shift workers - has well-known anti-inflammatory, anti-oxidant and anti-apoptotic effects that may well play a role in MS development19 29–32. It has been hypothesized that lower melatonin levels might be predictive of a higher MS risk and worse MS prognosis18 19 30. Our study adds information on the duration of rotating night shift work, suggesting that long-term (20+ years) exposure to frequent (≥3 nights/month) night shift work might play a role in the pathogenesis of MS.
The main strengths of this study include the prospective cohort design, large sample size, cumulative exposure (years) information and the MS case confirmation by a study physician/neurologist. This study also has some limitations. First, in the NHS, rotating night shift work exposure was assessed in 1988 only and information was not updated through follow-up. However, women at baseline were middle-aged and therefore were likely to have correctly reported their cumulative shift work exposure throughout a large part of their careers. Second, although this was a prospective analysis, rotating night shift work history was assessed retrospectively at baseline and exposure misclassification might have occurred, but most likely non-differential (to the null) since all subjects were healthy at baseline. Third, although our analysis was adjusted for most of the known predictors of MS23 24, multivariable models were not adjusted for past history of infectious mononucleosis, since this information was not routinely collected in these cohorts. Infectious mononucleosis is a risk factor for MS that might have temporarily affected the nurses’ work status but most likely not the total years of night shift work, therefore there is a small confounding potential that could have attenuated our findings. Fourth, risk estimates in NHS were unstable since these analyses were based on a small number of incident MS cases. Last, due to the older age of women at baseline in both cohorts –but especially in the NHS cohort we were only able to assess later life MS diagnosis. Given that onset of MS typically occurs in young adulthood, and that early life MS onset may not fully share the same etiology with later in life MS onset, our results need to be interpreted with caution.
In conclusion, in these two large prospective studies we found no overall evidence of an association between rotating night shift work and MS risk. In NHSII, shift work history of 20 or more years was associated with an increased MS risk, based on a small number of MS cases. More studies are needed to confirm the possible role of night shift work in MS development. While larger cohort studies might not be feasible, case-control or register based studies specifically for MS may help delineate this association. In addition to night work other sources of circadian and sleep disruption (e.g. light at night exposure and screen use among adolescents and young adults) might be of relevance for MS development and could be considered in future studies.
Supplementary Material
Key messages.
What is already known about this subject?
Shift work that involves circadian disruption has been associated with a wide range of chronic disease outcomes such as cancer, cardiovascular disease and recently autoimmune diseases.
Night shift work has been suggested as a possible risk factor for multiple sclerosis (MS) but epidemiological evidence is still limited.
What are the new findings?
This is the first prospective evaluation of night work in relation to MS risk.
Although we found no overall evidence of an association between night work and MS, risk of a definite MS diagnosis significantly increased after 20 years of night work.
How might this impact on policy or clinical practice in the foreseeable future?
More studies are needed to confirm the possible role of night shift work in MS development.
Night workers may benefit from preventive measures and disease screening programs at the workplace, already at early career stages.
Acknowledgements:
The authors thank the participants in the Nurses’ Health Study and Nurses’ Health Study II for their continuing cooperation and Leslie Unger for technical assistance.
Funding:
Supported by the US National Institutes of Health (grants T32 HL007575, UM1 CA186107, UM1 CA176726, R01NS046635).
Author Disclosures:
Dr. Papantoniou reports no disclosures
Dr. Massa reports no disclosures
Dr. Devore has received consulting fees from Epi Excellence and Bohn Epidemiology.
Dr. Munger reports no disclosures.
Dr. Chitnis reports no disclosures.
Dr. Ascherio receives research support from the US Department of Defense (Army) [W81XWH-05–1-0117 (PI)], the NIH [R01 NS045893 (PI), R01 NS047467 (PI), R01 NS48517 (PI), NINDS R01 NS042194 (PI), and R01 NS046635 (PI)]
Dr. Schernhammer reports no disclosures.
REFERENCES
- 1.Papantoniou K, Castano-Vinyals G, Espinosa A et al. Night shift work, chronotype and prostate cancer risk in the MCC-Spain case-control study. Int J Cancer 2015;137:1147–57. [DOI] [PubMed] [Google Scholar]
- 2.Vetter C, Devore EE, Wegrzyn LR et al. Association Between Rotating Night Shift Work and Risk of Coronary Heart Disease Among Women. JAMA 2016;315:1726–34. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Wegrzyn LR, Tamimi RM, Rosner BA et al. Rotating Night-Shift Work and the Risk of Breast Cancer in the Nurses’ Health Studies. Am J Epidemiol 2017;186:532–540. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Schernhammer ES, Laden F, Speizer FE et al. Night-shift work and risk of colorectal cancer in the nurses’ health study. J Natl Cancer Inst 2003;95:825–8. [DOI] [PubMed] [Google Scholar]
- 5.Gustavsen S, Sondergaard HB, Oturai DB et al. Shift work at young age is associated with increased risk of multiple sclerosis in a Danish population. Mult Scler Relat Disord 2016;9:104–9. [DOI] [PubMed] [Google Scholar]
- 6.Hedstrom AK, Akerstedt T, Olsson T, Alfredsson L. Shift work influences multiple sclerosis risk. Mult Scler 2015;21:1195–9. [DOI] [PubMed] [Google Scholar]
- 7.Magrini A, Pietroiusti A, Coppeta L et al. Shift work and autoimmune thyroid disorders. Int J Immunopathol Pharmacol 2006;19:31–6. [PubMed] [Google Scholar]
- 8.Puttonen S, Oksanen T, Vahtera J et al. Is shift work a risk factor for rheumatoid arthritis? The Finnish Public Sector study. Ann Rheum Dis 2010;69:779–80. [DOI] [PubMed] [Google Scholar]
- 9.Li WQ, Qureshi AA, Schernhammer ES, Han J. Rotating night-shift work and risk of psoriasis in US women. J Invest Dermatol 2013;133:565–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Hedstrom AK, Akerstedt T, Hillert J, Olsson T, Alfredsson L. Shift work at young age is associated with increased risk for multiple sclerosis. Ann Neurol 2011;70:733–41. [DOI] [PubMed] [Google Scholar]
- 11.Labrecque N, Cermakian N. Circadian Clocks in the Immune System. J Biol Rhythms 2015;30:277–90. [DOI] [PubMed] [Google Scholar]
- 12.Buenafe AC. Diurnal rhythms are altered in a mouse model of multiple sclerosis. J Neuroimmunol 2012;243:12–7. [DOI] [PubMed] [Google Scholar]
- 13.Faraut B, Boudjeltia KZ, Vanhamme L, Kerkhofs M. Immune, inflammatory and cardiovascular consequences of sleep restriction and recovery. Sleep Med Rev 2012;16:137–49. [DOI] [PubMed] [Google Scholar]
- 14.Papantoniou K, Pozo O, Espinosa A et al. Circadian variation of melatonin, light exposure and diurnal preference in day and night shift workers of both sexes. Cancer Epidemiol Biomarkers Prev 2014. [DOI] [PubMed] [Google Scholar]
- 15.Lange T, Dimitrov S, Born J. Effects of sleep and circadian rhythm on the human immune system. Ann N Y Acad Sci 2010;1193:48–59. [DOI] [PubMed] [Google Scholar]
- 16.Vogel M, Braungardt T, Meyer W, Schneider W. The effects of shift work on physical and mental health. J Neural Transm (Vienna) 2012;119:1121–32. [DOI] [PubMed] [Google Scholar]
- 17.Sandyk R. Multiple sclerosis: the role of puberty and the pineal gland in its pathogenesis. Int J Neurosci 1993;68:209–25. [DOI] [PubMed] [Google Scholar]
- 18.Farez MF, Mascanfroni ID, Mendez-Huergo SP et al. Melatonin Contributes to the Seasonality of Multiple Sclerosis Relapses. Cell 2015;162:1338–52. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Damasceno A, Moraes AS, Farias A, Damasceno BP, dos Santos LM, Cendes F. Disruption of melatonin circadian rhythm production is related to multiple sclerosis severity: A preliminary study. J Neurol Sci 2015;353:166–8. [DOI] [PubMed] [Google Scholar]
- 20.Alvarez-Sanchez N, Cruz-Chamorro I, Diaz-Sanchez M et al. Melatonin reduces inflammatory response in peripheral T helper lymphocytes from relapsing-remitting multiple sclerosis patients. J Pineal Res 2017. [DOI] [PubMed] [Google Scholar]
- 21.Hernan MA, Olek MJ, Ascherio A. Geographic variation of MS incidence in two prospective studies of US women. Neurology 1999;53:1711–8. [DOI] [PubMed] [Google Scholar]
- 22.Rimm EB, Giovannucci EL, Stampfer MJ, Colditz GA, Litin LB, Willett WC. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol 1992;135:1114–26; discussion 1127–36. [DOI] [PubMed] [Google Scholar]
- 23.Ascherio A, Munger KL. Epidemiology of Multiple Sclerosis: From Risk Factors to Prevention-An Update. Semin Neurol 2016;36:103–14. [DOI] [PubMed] [Google Scholar]
- 24.Ascherio A, Munger KL, Lunemann JD. The initiation and prevention of multiple sclerosis. Nat Rev Neurol 2012;8:602–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Pedersen OB, Erikstrup C, Kotze SR et al. The Danish Blood Donor Study: a large, prospective cohort and biobank for medical research. Vox Sang 2012;102:271. [DOI] [PubMed] [Google Scholar]
- 26.Rigas AS, Skytthe A, Erikstrup C et al. The healthy donor effect impacts self-reported physical and mental health - results from the Danish Blood Donor Study (DBDS). Transfus Med 2017. [DOI] [PubMed] [Google Scholar]
- 27.Besedovsky L, Lange T, Born J. Sleep and immune function. Pflugers Arch 2012;463:121–37. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Faraut B, Bayon V, Leger D. Neuroendocrine, immune and oxidative stress in shift workers. Sleep Med Rev 2013;17:433–44. [DOI] [PubMed] [Google Scholar]
- 29.Esposito E, Cuzzocrea S. Antiinflammatory activity of melatonin in central nervous system. Curr Neuropharmacol 2010;8:228–42. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Melamud L, Golan D, Luboshitzky R, Lavi I, Miller A. Melatonin dysregulation, sleep disturbances and fatigue in multiple sclerosis. J Neurol Sci 2012;314:37–40. [DOI] [PubMed] [Google Scholar]
- 31.Wang X. The antiapoptotic activity of melatonin in neurodegenerative diseases. CNS Neurosci Ther 2009;15:345–57. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Ochoa JJ, Diaz-Castro J, Kajarabille N et al. Melatonin supplementation ameliorates oxidative stress and inflammatory signaling induced by strenuous exercise in adult human males. J Pineal Res 2011;51:373–80. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.